Orbit 10
The COVID-19 pandemic has been incredibly disruptive for people all across the world, but has really thrown the spotlight on pharma companies. We’ve seen drugs designed and developed in record times. We’ve seen more collaboration between scientists, pharma companies and regulators than ever before – collaboration that has seen sharing of science, approaches and data. This has accelerated an ongoing trend in pharma, as pharma companies have become more and more data-centric and data-savvy. In this episode, Hg’s Amr Ellabban speaks with Jon Moser, SVP, Innovation, Research & Development at Evaluate, and explains how biopharma’s approach to data science has changed and what we’re likely to see going forward.

Norstella was formed following the merger of MMIT Evaluate and Pharma Intelligence (Citeline, previously part of Informa). Each of its brands (Evaluate, MMIT, Panalgo, The Dedham Group, Citeline) delivers must-have answers for critical strategic and commercial decision-making.
By combining the efforts of each organization under Norstella, they can offer breadth of expertise, cutting-edge data solutions and expert advisory services alongside advanced technologies such as real-world data, machine learning and predictive analytics.
View more








